Your browser doesn't support javascript.
loading
Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper.
Battisti, Nicolò Matteo Luca; De Glas, Nienke; Sedrak, Mina S; Loh, Kah Poh; Liposits, Gabor; Soto-Perez-de-Celis, Enrique; Krok-Schoen, Jessica L; Menjak, Ines B; Ring, Alistair.
Afiliação
  • Battisti NML; Department of Medicine - Breast Unit, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK.
  • De Glas N; Department of Medical Oncology, Leiden University Medical Center, Netherlands.
  • Sedrak MS; Department of Medical Oncology & Therapeutics Research, City of Hope, USA.
  • Loh KP; Division of Hematology/Oncology, University of Rochester Medical Center, USA.
  • Liposits G; Department of Oncology, Regionhospitalet Herning, Denmark.
  • Soto-Perez-de-Celis E; Department of Geriatrics, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
  • Krok-Schoen JL; Division of Medical Dietetics and Health Sciences, The Ohio State University, Columbus, OH, USA.
  • Menjak IB; Department of Medicine, University of Toronto, Toronto, Ontario, USA.
  • Ring A; Department of Medicine, The Royal Marsden NHS Foundation Trust, UK.
Ther Adv Med Oncol ; 10: 1758835918809610, 2018.
Article em En | MEDLINE | ID: mdl-30479671
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido